Podcasts & RSS Feeds
Most Active Stories
- What's Next For Pensions, Now That Court Has Tossed Illinois' Law?
- Power Players – Who’s In And Who’s Out When It Comes To Lobbying The New Governor
- Lawmakers Propose Adding Crime Victims' Bill Of Rights To Illinois Law
- How Much Is Your AP Test Score Worth In Illinois? The Answer Varies By University
- New Pension Fixes May Emerge; Rauner Considering Ideas That "Haven't Been Brought Forward Yet"
Thu August 7, 2014
Company Seeks Approval For Experimental Ebola Drug
There is no known cure for the Ebola virus, but a number of labs have been working on one. The two American relief workers recently flown back from Liberia have been receiving an experimental treatment produced by a company in San Diego.
Another company, Cambridge, Mass.-based Sarepta Therapeutics, also has an experimental drug. The company’s CEO, Chris Garabedian, tells Here & Now’s Robin Young how this treatment would work, and what it takes to get the drug to patients.
- Chris Garabedian, CEO of Sarepta Therapeutics.